Drug shows promise for Huntington's disease

Courtesy EurekAlert! - Medicine and Health  Sun, 02/07/2010 - 23:00

(University of Rochester Medical Center) An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition.

That is the conclusion of a study published today in the Archives of Neurology.


 

More related items

Starve a virus, feed a cure?
(University of Rochester Medical Center) A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building...

US patent awarded for Rochester's pioneering HPV...
(University of Rochester Medical Center) The University of Rochester has been awarded a US patent for research essential to both human papillomavirus vaccines on the market. The patent is for...

Unexpected find opens up new front in effort to stop...
(University of Rochester Medical Center) HIV adapts in a surprising way to survive and thrive in its hiding spot within the human immune system, scientists have learned. The the finding helps...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com